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longed illness due to nonbacterial pathogens such as fungi, mycobacteria, or Actinomycetes.20,2' The diseases described as predisposing to chronic bacterial pneumonia include pulmonary anatomic abnormalities such as neoplastic bronchial obstruction, bronchiectasis, and pulmonary cysts/bullae, and systemic deficiencies of host resistance, including AIDS, hematologic malignancy, and dysproteinemias. 21 In 1978, we began to use quantitative culture of a cytology brush specimen of lower respiratory secretions obtained at fiberoptic bronchoscopy (FOB) to diagnose bacterial pneumonia. The presence of 4,000 or more colony-forming units (CFUs) of a single bacterial species has proved to be an accurate standard for recognizing bacterial infection in nonintubated patients.22 A review of our results over 12 years identified 115 patients with lower respiratory bacterial infection of greater than 1 month's duration. The clinical presentation, predisposing diseases, roentgenography, bacteriology, bronchoalveolar lavage (BAL) cell populations, response to medical therapy, and long-term outcome of these 115 patients are the subjects of this report. This is the largest group of patients with chronic bacterial pneumonia recorded in the medical literature.
MATERIAL AND METHODS

Collection of Specimens
Fiberoptic bronchoscopy was performed with an Olympus BF-P20 bronchoscope (Olympus Corporation of America, New Hyde Park, NY) under topical lidocaine anesthesia. The tip of the bronchoscope was guided by direct vision into the lobar or segmental airway leading to the radiographic abnormality. A sterile, single-sheathed, number 149 3-mm disposable bronchial cytology brush (Mill-Rose Laboratories, Mentor, Ohio) was advanced through the side channel of the bronchoscope and into the airway. 22 The brush was then unsheathed, guided into the visualized secretions, and rotated gently to obtain a maximal inoculation of secretions.
Quantitative Culture Brush specimens were processed by the microbiology laboratory within 15 min of their collection. The cytology brush was unsheathed, cut from the guidewire, and dropped into a test tube containing 1 ml of thioglycolate broth. The test tube was agitated for 30 s with a vortex mixture and then a loop with 0.01 ml volume was inoculated into chocolate agar and sheep blood plates for aerobic and anaerobic cultuire. respectivelv. Each coloniallv distinct micro-organism was counted separately. A retrospective chart review was performed on all patients with 4,000 or more CFUs of a single bacterial species on quantitative culture of a brush specimen obtained at FOB. All patients included in the study group had (1) an abnormal chest roentgenogram; (2) respiratory symptoms (cough, hemoptysis, chest pain, dyspnea) and/or constitutional symptoms (fever [>37.7°C for -5 days], weight loss, malaise, fatigue) of more than 1-month's duration; and (3) no tracheal intubation or mechanical ventilation during the course of the respiratory illness. Confirmation of a chronic bacterial pneumonia required resolution of symptoms and x-ray film abnormalities after appropriate antibiotic therapy in those patients without rapidly fatal disease. Recurrent infection was defined as a return of symptoms and roentgenographic abnormality in the 6-month period after cessation of antibiotics. Patients with roentgenographic evidence of lung abscess were excluded from consideration.
The clinical records of patients meeting these criteria were reviewed for demographics, type, and duration of symptoms, history of prior antibiotic therapy for the respiratory illness, laboratory data (WBC count, hematocrit, erythrocyte sedimentation rate, and prebronchoscopy sputum analysis), chest roentgenogram findings, and prebronchoscopy clinical impression. Associated illnesses were carefully recorded for each patient to identify pulmonary anatomic abnormalities, immunosuppressive therapy, or systemic illness considered to predispose to chronic bacterial respiratory infection. Bronchoscopic data analyzed included visual findings (purulent lower respiratory secretions and/or mucosal erythema), bronchoalveolar lavage cell populations, and histologic findings on transbronchial biopsy (TBBX). The therapeutic outcome and incidence of recurrence were analyzed in relation to the duration of appropriate antibiotic therapy.
Statistics
The BAL cell population comparison was performed using the two-tail t test. Response to therapy was evaluated using Fischer's exact test. A p<O.05 was considered significant.
RESULTS
Patient Population
From January 1, 1978 22. Only ten patients were receiving prednisone for their obstructive airflow disease at the time of onset of chronic pneumonia. Twenty-seven of the patients with obstructive airflow disease were former or current smokers, seven had asthma, and one suffered from alpha-1-antitrypsin deficiency The chronic pneumonitis was distal to an obstructing endobronchial neoplasm in 15 patients and occurred coincidently with carcinoma but in the absence of endobronchial obstruction in 7. Bronchogenic carcinoma was newly recognized at the time of diagnosis of the chronic pneumonia in 16 of the 22 patients. Four patients had nonneoplastic bronchial obstruction and distal pneumonia. One patient had aspirated a vitamin tablet, two had aspirated vegetable matter, and one patient had an airway cicatrix after surgical bronchoplasty for bronchogenic carcinoma without evidence of recurrent lung cancer. Two patients with idiopathic pulmonary fibrosis had chronic bacterial pneumonia as a late complication of their interstitial lung disease (ILD). One patient with sarcoid and another with pulmonary histiocytosis X had their ILD initially recognized at the time of diagnosis of the chronic pneumonia. None of the four patients were on corticosteroids when the infection occurred.
There were only two patients with bronchiectasis and three with HIV infection in the chronic bacterial pneumonia group. Thoracic CT scans or, less commonly, bronchograms were performed for investigation of suspected bronchiectasis in 31 patients. Bronchiectasis may be under recognized in our patients.
Patients With No Predisposing Disease
Forty patients had no recognizable predisposing disease to explain their chronic pneumonia. All patients were followed up for 6 months or longer without pulmonary or systemic disease recognized. This group includes one patient with a history of alcohol abuse who had been abstinent for 1 year, three patients with a history of asthma who had no evidence of obstructive airflow disease during the pneumonic episode and no recent steroid therapy, and four patients with collagen vascular disease (two with Sjogren's syndrome, two with rheumatoid arthritis) without ILD or current therapy. The average age at time of presentation was 62 years (range 23 to 83). Eight patients were current smokers, 7 were former smokers, and 25 had never smoked.
Clinical Presentation
The clinical presentation of chronic bacterial pneumonia was similar in patients with and without predisposing disease. The onset of illness was typically insidious without a defining initial event. The mean duration of symptoms before diagnosis was 5.5 months in patients with predisposing disease and 5.9 months in patients without predisposing disease. Table 2 details the symptoms at presentation for the two groups. The most common symptom was cough, which was present in 103 (90 percent) of all patients. However, cough was productive of 30 ml or more of sputum daily in only 40 percent of patients with predisposing disease and 45 percent of patients without. The second most common respiratory symptom was dyspnea, which occurred in 57 percent of patients with predisposing disease and 43 percent of those without. The increase in prevalence of dyspnea in patients with predisposing disease is probably the result of an underlying pulmonary disease. Chest pain occurred in 31 percent of all patients and was more common in patients without underlying disease. The chest pain was usually more compatible with musculoskeletal discomfort due to cough than with the effects of pleural inflammation. Hemoptysis occurred in 17 percent of patients and was equal in prevalence in both groups.
Malaise/fatigue was the prevalent constitutional symptom and was second only to cough in frequency. Ninety-four (82 percent) patients reported this symptom. Weight loss occurred in 51 patients (44 percent) and was slightly more common in those with underlying disease than in subjects without a predisposing condition. A history of fever was present in only 25 (22 percent) of 115 patients and was more common in those without predisposing disease.
ROENTGENOGRAPHY
The appearance on chest roentgenogram was similar for the two groups and ranged from lobar consolidation to diffuse patchy parenchymal disease (Fig 1 and 2) . Fifty-seven percent of all patients presented with parenchymal disease limited to a single lobe or segment. This was true in 60 percent of patients with predisposing disease and 53 percent of those without predisposing disease. Overall, 35 (71 percent) of 49 patients with multilobar involvement had bilateral disease. Bilateral pneumonia was seen in 28 percent of patients with predisposing disease and 35 percent of those without. All lobes were at risk with-the lower lobes involved most often. Only six patients (5 percent of each group) had associated pleural effusions. In 11 patients without predisposing disease and in 31 patients with predisposing disease, the initial roentgenographic interpretation raised the possibility of bronchogenic carcinoma.
LABORATORY FINDINGS
The peripheral blood WBC count was recorded in 71 patients with predisposing disease and ranged from 300 to 70,000/mm3. Forty-nine (69 percent) patients had a WBC between 4,000 and 11,000/mm3 while 17 had a WBC more than 11,000/mm3, and 5 had a WBC less than 4,000/mm3. Nineteen (27 percent) of 72 patients with predisposing disease were anemic (Hct <34 percent for women, <40 percent for men) at the time of presentation. The ESR ranged from 0 to 125 mm/h and was normal (<20 in women, .15 in men) in only 10 patients.
The peripheral WBC count was recorded for 37 of the 40 patients without a predisposing illness, and ranged from 4,600 to 19,000/mm3. Twenty-nine (81 percent) of these patients had a WBC count of 11,000/mm3 or less. Twenty-nine patients had a normal hematocrit and 8 (22 percent) were anemic. The ESR ranged from 6 to 122 and was normal in only 4 patients. Bacteriology
Eighty-eight bacteria with 4,000 or more CFUs on brush culture were isolated from the 75 patients with predisposing disease and 45 bacteria were isolated from the 40 patients without predisposing disease (Table 3) . Although 25 different species of bacteria were isolated from the 115 patients, the same five bacteria in the same order of prevalence accounted for 77 percent (68/88) of isolates from patients with predisposing disease and 82 percent (37/45) of isolates from those without predisposing disease (Table 3) . Haemophilus influenzae was isolated from 46 percent of all patients, alpha-hemolytic streptococcus from 22 biotics received were judged to be effective against the organism subsequently isolated by quantitative culture. Sixty-three percent of patients noted transient improvement while on antibiotics, but again there was a rapid recurrence of symptoms within 7 days of finishing the medication.
Postbronchoscopy Treatment: Fourteen patients with a predisposing illness lived less than 6 months postbronchoscopy. Eight of these patients had "rapidly fatal illness"24 and died while receiving antibiotic therapy, making it impossible to track the outcome of the respiratory infection. The remaining six patients, four patients with lung cancer, one patient with lymphoma, and one patient receiving chemotherapy for breast cancer, had complete resolution of symptoms and improvement in the chest x-ray film abnormality with antibiotic therapy before death, consistent with the clearance of their pneumonia. There were 61 patients with predisposing disease who survived more than 6 months after treatment for their pneumonia. Eighteen of these patients received 2 weeks or less of effective therapy, and eight (44 percent) suffered a recurrent infection within the 6-month follow-up. Thirteen patients received 2 to 4 weeks of effective antibiotic treatment and six (46 percent) had a recurrence. The remaining 30 patients received 4 weeks or more of therapy and 8 (27 percent) developed a recurrent infection in the following 6 months.
Two of 3 patients with HIV infection, 4 of 12 patients with lung cancer, and 10 of 20 patients with COPD had a recurrence of infection within 6 months. In contrast, only one of four patients with ILD (the patient received 5 days of therapy) and none of the four patients with diabetes had a recurrence of infection.
Of the 40 patients without any predisposing illness, recurrences were observed in 3 of the 4 (75%) patients treated for less than 2 weeks, 3 of 6 (50%) patients treated for 2 to 4 weeks, and 5 of 30 (17 percent) treated for 4 weeks or more. There was a significant difference in recurrence rate in those treated less than 4 weeks compared with those treated for 4 weeks or more (p=0.01).
DISCUSSION
The reports of patients with chronic bacterial pneumonia published between 1911 and 1967 defined the histology of the infection, debated whether the illness was a chronic sequela of an acute infection, identified Klebsiella pneumoniae (Friedlander's bacillus) as a pathogen common in this illness, and emphasized underlying bronchiectasis and lung abscess as contributing to propagation of the chronic infection.2-16 Most of the series suffer from a lack of precise microbiology. A collective clinical picture, however, emerges similar to that of our patients. The average duration of symptoms ranged from 4.5 to 11.5 months, cough was the most common symptom, and chest pain and hemoptysis were frequent. Fever was found in less than half of the patients. Constitutional symptoms such as fatigue and weight loss were sometimes predominant and patients were often suspected of having bronchogenic carcinoma. There were only 13 patients with microbiologic specimens obtained at surgery or necropsy. 5, 6 In contrast to our results, the infections were frequently polymicrobial and included alpha-hemolytic streptococci isolated from seven patients, beta hemolytic streptococci from three patients, gamma-hemolytic streptococci from two patients, S aureus from two patients, Staphylococcus albus from four patients, S pneumoniae from two patients, and Klebsiella pneumoniae from one patient.
The current series is the first to use a reliable nonoperative invasive technique for antemortem diagnosis of chronic lower respiratory bacterial infection. We have previously reported our experience with quantitative brush culture and immunofluorescence demonstration of antibody coated bacteria in recognizing lower respiratory bacterial infection in nonintubated patients. 22 This method seems to us to be the best technique currently available for defining this clinical entity during life. We arbitrarily selected a duration of disease of greater than 1 month as defining chronic pneumonia while previous studies have used a duration of symptoms varying from 2 to 10 weeks. In the 12-year period reviewed, we found 115 patients meeting our definition of chronic bacterial pneumonia. It strongly suggests that use of refined techniques will prove chronic lower respiratory infection to be much more common than previously appreciated.
Chronic pneumonia occurred more frequently in women than men and over a very broad age range. Seventy-five patients had associated diseases known to predispose to infection. Sixty-seven patients had primary pulmonary abnormalities, including 34 with COPD/asthma and 22 patients with intrathoracic malignant lesions. The latter group was particularly interesting. Bronchogenic carcinoma was newly recognized at the time of diagnosis of the chronic pneumonia in 16 of the 22 The presence of bacteria in the lower respiratory tract in patients with underlying disease raises the question of saprophytic colonization true vs true bacterial pathogen. Our inclusion criteria required resolution of symptoms and x-ray film abnormalities after appropriate antibiotic therapy in patients without rapidly fatal disease in an effort to define the role of the bacteria isolated. One hundred and seven patients showed such improvement, including six with rapidly fatal associated disease.
Surprisingly, 40 patients (35 percent) had no recognizable predisposing disease to explain their chronic pneumonia. Chronic bacterial pneumonia in normal patients has not been emphasized previously. An average of 5 months of respiratory symptoms was reported in the typical case. Onset of symptoms was often insidious with no defining acute event. Cough was present in 98 percent of patients but a history of production of more than 30 ml of sputum daily was present in less than half. Despite the absence of a history of production of purulent sputum in most patients, fiberoptic bronchoscopy visually showed evidence of purulent secretions in 90 percent of patients without predisposing disease. Only a third of the patients had fever. Fatigue, dyspnea, chest pain, weight loss, and hemoptysis were not uncommon and mimicked the presentation of neoplastic disease. The patients typically had received one or more 7-to 14-day courses of antibiotics with transient improvement followed by early recurrence of symptoms. Eighty percent of patients had a WBC count less than 11,000/mm3, the minority were anemic, and only an elevated ESR was common to the majority.
The near identical clinical presentation, bacteriology, roentgenographic appearance, and short-term response to treatment of chronic bacterial pneumonia in patients with and without predisposing disease has important clinical implications. All patients with chronic bacterial pneumonia should be evaluated for underlying disease, especially bronchogenic carcinoma.
The roentgenographic appearance of chronic pneumonia varied from unifocal parenchymal disease mimicking tumor to multifocal parenchymal disease. All lobes were affected with the lower lobes predominantly involved. Pleural effusion was found in only six patients. There appeared to be no difference in radiographic appearance between the two groups.
Haemophilus influenzae was the most common pathogen in patients both with and without predisposing disease. It was found in 41 percent of patients with predisposing disease and in 55 percent of those without associated disease. Alpha-hemolytic streptococcus was the second most common pathogen and isolated from 24 percent of patients with predisposing disorders and from 18 percent of normal patients. The alpha-hemolytic streptococci were not speciated. Previous reports have emphasized that pneumonia secondary to either of these organisms has typically been acute in onset with productive cough, fever, chills, and pleuritic chest pain the common symptoms.25-28 While many alpha-hemolytic streptococci are not considered pathogenic, the Streptococcus milleri group has been recognized to cause a variety of chronic pleuropulmonary syndromes including aspiration pneumonia, lung abscess, and empyema. 29 It is important to emphasize that H influenzae and alpha-hemolytic streptococcus are both constituents of "normal respiratory flora." Their presence as pathogens will often be missed by sputum culture. FOB with quantitative culture technique will be necessary to recognize the infection in most.
Therapeutic outcome was related to duration of therapy and the presence of predisposing disease. Twenty-two of the 61 (36 percent) patients with predisposing disease who were evaluable had a recurrence of infection within 6 months, including 8 of 30 (27 percent) who received 4 weeks or more of antibiotics. Recurrence of infection was recognized in 10 of the 40 (25 percent) patients without predisposing illness including 5 of the 30 (17 percent) treated for 4 weeks or more. Among the 32 patients with recurrence, the initial and recurrent infection were both the result of the same bacterial species in 7 of 10 patients who had a repeat FOB to evaluate the recurrence. Three patients recurred with a polymicrobial infection.
We offer the following conclusions: (1) Chronic bacterial pneumonia is more common than previously recognized; (2) Sixty-five percent of patients with chronic bacterial pneumonia will have a recognizable predisposing disease. However, 35 percent of patients with chronic bacterial lower respiratory infection have no recognizable associated disease; (3) Chronic bacterial pneumonia commonly presents in the absence of a history of fever and the production of purulent sputum. Although cough is the most common symptom, constitutional symptoms such as fatigue and weight loss are also frequent; (4) H influenzae and alpha-hemolytic streptococcus are the most common bacterial pathogens in this syndrome, in patients both with and without predisposing illness; (5) The roentgenographic appearance is variable and may mimic either neoplasm or interstitial lung disease. Pleural effusion is rare; (6) Successful treatment requires 4 weeks or more of appropriate antibiotic administration. Shorter courses of therapy have a high incidence of recurrence despite the occurrence of symptomatic improvement; (7) Fiberoptic bronchoscopy should be considered essential for the evaluation of patients suspected of having chronic pneumonia since 14 percent of such patients have an underlying, previously unrecognized bronchogenic carcinoma and 3 percent have benign endobronchial disease predisposing to the infection; and (8) FOB with quantitative brush culture is the most reliable, currently available technique for the recognition of chronic bacterial pneumonia.
